Brian L. Hazleman

Brian L. Hazleman's AcademicInfluence.com Rankings

Brian L. Hazleman

Medical

#3092

World Rank

#3546

Historical Rank

Rheumatology

#27

World Rank

#28

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Brian L. Hazleman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Brian L. Hazleman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative (2012) (531)
Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. (2002) (530)
Tendon degeneration and chronic shoulder pain: changes in the collagen composition of the human rotator cuff tendons in rotator cuff tendinitis. (1994) (347)
Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. (2002) (346)
Diagnosis and relation to general health of shoulder disorders presenting to primary care. (2005) (337)
The vasculature and its role in the damaged and healing tendon (2002) (323)
Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study. (1986) (315)
Humanised monoclonal antibody therapy for rheumatoid arthritis (1992) (301)
Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human achilles tendon. (2006) (297)
Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study. (1988) (270)
Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution (2007) (259)
Multiple changes in gene expression in chronic human Achilles tendinopathy. (2001) (249)
Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller. (1995) (239)
2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. (2012) (231)
Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis. (1994) (226)
Is therapeutic ultrasound effective in treating soft tissue lesions? (1985) (199)
PULSED ELECTROMAGNETIC FIELD THERAPY OF PERSISTENT ROTATOR CUFF TENDINITIS A Double-blind Controlled Assessment (1984) (178)
The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. (1993) (172)
The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. (1983) (158)
Prognosis and management of polymyalgia rheumatica. (1981) (158)
Lateral humeral epicondylitis--a study of natural history and the effect of conservative therapy. (1983) (153)
Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy. (2006) (143)
Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months. (1989) (142)
Shoulder pain in a community-based rheumatology clinic. (1995) (142)
Lysylhydroxylation and non-reducible crosslinking of human supraspinatus tendon collagen: changes with age and in chronic rotator cuff tendinitis (1999) (135)
Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. (1989) (131)
Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects. (1989) (128)
The sclera and systemic disorders (1976) (121)
Tenascin-C and human tendon degeneration. (1996) (120)
Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica. (2007) (118)
A controlled study of oral prednisolone in frozen shoulder. (1986) (118)
Extracorporeal shock-wave therapy for tendonitis of the rotator cuff. A double-blind, randomised, controlled trial. (2002) (113)
CAMPATH-1H in rheumatoid arthritis--an intravenous dose-ranging study. (1996) (111)
Calcific tendinitis of the shoulder. (1999) (111)
Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine. (1980) (105)
A double-blind study of the effectiveness of low level laser treatment of rotator cuff tendinitis. (1993) (105)
Pulsed low-intensity ultrasound therapy for chronic lateral epicondylitis: a randomized controlled trial. (2006) (104)
PROSTAGLANDIN E1 AND PERIPHERAL VASCULAR DISEASE (1983) (103)
CAMPATH-1H, a humanized monoclonal antibody, in refractory rheumatoid arthritis. An intravenous dose-escalation study. (1995) (102)
Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1beta in human tendon-derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy. (2002) (101)
Inhibition of Tendon Cell Proliferation and Matrix Glycosaminoglycan Synthesis by Non-Steroidal Anti-Inflammatory Drugs in vitro (2001) (93)
The painful stiff shoulder. (1972) (93)
A controlled study of acupuncture in neck pain. (1986) (87)
Azathioprine in Rheumatoid Arthritis (1969) (87)
Metalloproteinases and collagenase inhibitors in rheumatoid synovial fluid. (1984) (83)
Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia. (2001) (82)
Transforming growth factor beta stimulates the production of the tissue inhibitor of metalloproteinases (TIMP) by human synovial and skin fibroblasts. (1991) (82)
Histopathological assessment and pathological significance of matrix degeneration in supraspinatus tendons. (2001) (77)
Supervision of Epileptic Patients Taking Phenytoin (1970) (75)
Novel treatment for joint inflammation (1978) (75)
A double-blind trial comparing subacromial methylprednisolone and lignocaine in acute rotator cuff tendinitis. (1993) (74)
Prevalence and possible pathological significance of calcium phosphate salt accumulation in tendon matrix degeneration. (1996) (73)
The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment. (1993) (71)
Human shoulder tendon biopsy samples in organ culture produce procollagenase and tissue inhibitor of metalloproteinases. (1995) (69)
Transforming growth factor-beta causes partial inhibition of interleukin 1-stimulated cartilage degradation in vitro. (1989) (69)
Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud's phenomenon. (1992) (68)
Versican splice variant messenger RNA expression in normal human Achilles tendon and tendinopathies. (2004) (65)
LIPOSOMES IN ARTHRITIS: A NEW APPROACH (1979) (63)
The regulation of aggrecanase ADAMTS-4 expression in human Achilles tendon and tendon-derived cells (2008) (63)
Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis. (1989) (62)
Sarcoid-like granulomatous disease following etanercept treatment for RA. (2007) (61)
Community survey of shoulder disorders in the elderly to assess the natural history and effects of treatment. (1995) (61)
Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods. (1985) (59)
Heat distribution over normal and abnormal joints: thermal pattern and quantification. (1983) (58)
Disease activity indexes in rheumatoid arthritis; a prospective, comparative study with thermography. (1985) (57)
Endochondral ossification in Achilles and patella tendinopathy. (2002) (55)
Effects of single dose compared with three days' prednisolone treatment of healthy volunteers: contrasting effects on circulating lymphocyte subsets. (1993) (55)
Myofascial pain and fibromyalgia syndromes : a clinical guide to diagnosis and management (2001) (54)
Credibility of placebo transcutaneous nerve stimulation and acupuncture. (1985) (54)
Interrater reproducibility of clinical tests for rotator cuff lesions (2004) (53)
Acupuncture, Trigger Points and Musculoskeletal Pain (1990) (53)
Thermographic changes in keyboard operators with chronic forearm pain (1997) (53)
The diagnosis of stress fractures in athletes. (1984) (51)
Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis (1981) (51)
Wound healing after operations of patients with rheumatoid arthritis. (1973) (50)
Lymphocyte proliferation to artery antigen as a positive diagnostic test in polymyalgia rheumatica. (1975) (50)
Inhibition of interleukin-1beta-stimulated collagenase and stromelysin expression in human tendon fibroblasts by epigallocatechin gallate ester. (2004) (50)
Circulating levels of IL-1beta, IL-6 and soluble IL-2 receptor in polymyalgia rheumatica and giant cell arteritis and rheumatoid arthritis. (1998) (49)
A clinical and thermographic study of lateral epicondylitis. (1983) (48)
Effects of antirheumatoid drugs on the production and action of porcine catabolin. (1982) (46)
Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimens. (1985) (45)
Successful treatment of refractory polyarticular juvenile idiopathic arthritis with rituximab. (2006) (45)
A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis. (1995) (45)
Association of polymyalgia rheumatica and giant-cell arteritis with HLA-B8. (1977) (45)
Monoclonal antibodies against human fibroblast collagenase and the design of an enzyme-linked immunosorbent assay to measure total collagenase. (1992) (45)
Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomes. (2008) (44)
Changes in matrix protein biochemistry and the expression of mRNA encoding matrix proteins and metalloproteinases in posterior tibialis tendinopathy (2012) (44)
Long-term azathioprine in rheumatoid arthritis: a double-blind study. (1981) (43)
The timing of prednisolone dosage and its effect on morning stiffness in rheumatoid arthritis. (1984) (40)
Prolonged effect of CGRP in Raynaud's patients: a double-blind randomised comparison with prostacyclin. (1991) (39)
SELECTIVE SUPRASENSITIVITY TO CALCITONIN-GENE-RELATED PEPTIDE IN THE HANDS IN RAYNAUD'S PHENOMENON (1989) (38)
Contrasting effects of fluoroquinolone antibiotics on the expression of the collagenases, matrix metalloproteinases (MMP)-1 and -13, in human tendon-derived cells. (2005) (38)
Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders. (1973) (38)
Magnetic resonance imaging or arthrography of the shoulder: which do patients prefer? (1997) (36)
Identification of a new metalloproteinase inhibitor that forms tight-binding complexes with collagenase. (1990) (35)
Prostaglandin E1 vasospastic disease and thermography. (1985) (34)
Tendon lesions and soft tissue rheumatism--great outback or great opportunity? (1996) (31)
The role of cytokines in arthritic diseases: in vitro and in vivo measurements of cartilage degradation. (1987) (31)
Effect of energy conservation and joint protection education in rheumatoid arthritis. (1994) (31)
Ciprofloxacin reduces the stimulation of prostaglandin E(2) output by interleukin-1beta in human tendon-derived cells. (2003) (30)
Thermographic diagnosis in athletes with patellofemoral arthralgia. (1986) (30)
Pulsed methylprednisolone in active early rheumatoid disease: a dose-ranging study. (1988) (30)
Circulating immune complexes in polymyalgia rheumatica and giant cell arteritis. (1981) (29)
The secretion of the tissue inhibitor of metalloproteinases (TIMP) by human synovial fibroblasts is modulated by all-trans-retinoic acid. (1991) (29)
Immunological and histological study of temporal arteries. (1978) (29)
Synovial fluids from infected joints contain active metalloproteinases and no inhibitory activity. (1989) (29)
Factors relating to circulating immune complexes in rheumatoid arthirits. (1976) (27)
Assessment of inflammation in the rheumatoid knee joint: correlation between clinical, radioisotopic, and thermographic methods. (1986) (27)
Prostaglandin E-1 and peripheral vascular disease. (1983) (27)
Soft Tissue Rheumatology (2001) (27)
Yttrium-90 therapy and 99MTc pertechnetate knee uptake measurements in the management of rheumatoid arthritis. (1983) (26)
Scleritis and associated disease. (1978) (26)
The comparative incidence of malignant disease in rheumatoid arthritics exposed to different treatment regimens. (1982) (26)
Interaction of influenza A virus with human peripheral blood lymphocytes (1979) (25)
Rarity of synovitis in polymyalgia rheumatica. (1990) (25)
Purification of a metalloproteinase inhibitor from human rheumatoid synovial fluid. (1985) (25)
Polymyalgia rheumatica--a clinical study with particular reference to arterial disease. (1984) (25)
Polyclonal antibodies against human fibroblast collagenase and the design of an enzyme-linked immunosorbent assay to measure TIMP-collagenase complex. (1992) (24)
Isolation and growth characteristics of adult human tendon fibroblasts. (1987) (23)
Validation of clinical examination versus magnetic resonance imaging and arthroscopy for the detection of rotator cuff lesions (2013) (23)
α1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis (1994) (21)
Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1 β in human tendon-derived cells (2017) (20)
Successful treatment of dissecting aortic aneurysm due to giant cell arteritis. (1981) (20)
PAIRED SERUM AND SYNOVIAL FLUID VALUES OF α2-MACROGLOBULIN AND TIMP IN RHEUMATOID ARTHRITIS (1987) (20)
Investigation of auranofin-induced diarrhoea. (1986) (20)
Rapid purification of tissue inhibitor of metalloproteinases from human plasma and identification as a gamma-serum protein. (1986) (19)
Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment. (1993) (19)
Parallel studies of HLA antigens in patients with rheumatic heart disease and scleritis: comparisons with three control populations. (1977) (19)
A Pilot Randomised Placebo-controlled Trial Of Physiotherapy And Osteopathic Treatment For Frozen Shoulder (2003) (19)
HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS (1992) (18)
Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study. (1987) (18)
Safety and tolerability of rituximab in patients with moderate to severe rheumatoid arthritis: Results from the dose-ranging assessment international clinical evaluation of rituximab in rheumatoid arthritis (DANCER) study (2005) (18)
ESR in polymyalgia rheumatica and giant cell arteritis. (1983) (18)
Liver scan abnormalities in polymyalgia rheumatica/giant cell arteritis (1991) (17)
Effects of heparin, histamine, and salmon calcitonin on mouse calvarial bone resorption. (1986) (16)
Post-operative wound healing in patients with rheumatoid arthritis. (1973) (16)
Ocular manifestations of the rheumatic diseases. (1978) (16)
Giant cell arteritis of myometrial and axillary arteries and polymyalgia rheumatica. (1987) (15)
Survival after aortic dissection in giant cell arteritis. (1996) (15)
Synovial fluids from infected joints contain metalloproteinase--tissue inhibitor of metalloproteinase (TIMP) complexes. (1990) (15)
Isolation and analysis of immune complexes from sera of patients with polymyalgia rheumatica and giant cell arteritis. (1987) (14)
Erythrocyte sedimentation rate (ESR) at presentation is a prognostic indicator for duration of treatment in polymyalgia rheumatica (PMR) (1997) (14)
Long-term evaluation of naproxen suspension in juvenile chronic arthritis. (1982) (13)
Cytidine deaminase may be a useful marker in differentiating elderly onset rheumatoid arthritis from polymyalgia rheumatica/giant cell arteritis. (1995) (13)
Identification of tissue inhibitor of metalloproteinase-2 (TIMP-2)-progelatinase complex as the third metalloproteinase inhibitor peak in rheumatoid synovial fluid. (1993) (12)
Polymyalgia rheumatica/giant cell arteritis in a Cambridge general practice. (1985) (12)
The levels of collagenase, tissue inhibitor of metalloproteinases-1 (TIMP-1), collagenase approximately TIMP-1 complexes and glycosaminoglycan (GAG) in sequential samples of synovial fluid aspirated from patients with osteoarthritis. (1995) (11)
The sulphated glycosaminoglycan levels in synovial fluid aspirates in patients with acute and chronic joint disease. (1990) (11)
The effect of the anabolic steroid, stanozolol, on the production of procollagenase by human synovial and skin fibroblastsin vitro (1989) (10)
Giant-cell arteritis presenting to the dentist: a need for urgent diagnosis. (1983) (9)
Production of cartilage degrading activity by human synovial tissues. (1987) (9)
Rheumatoid factors in association with rheumatoid arthritis and infectious diseases in West Africans. (1994) (8)
A rapid and reproducible method for the analysis of immune complexes using affinity chromatography and Western blotting. (1985) (8)
Rheumatoid factor quantitation: a comparison of ELISA and nephelometric methods. (1991) (8)
Polymyalgia rheumatica/giant cell arteritis in husband and wife (1984) (7)
Modulation of plasminogen activator production by interleukin 1: differential responses of fibroblasts derived from human skin and rheumatoid and non-rheumatoid synovium. (1990) (7)
The Systemic Manifestations of Temporal Arteritis (1980) (7)
Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis. (1994) (7)
Abnormal radionuclide liver scans in giant cell arteritis. (1984) (7)
A comparative study of the long-term efficacy of flurbiprofen and indomethacin in the treatment of rheumatoid arthritis, with special reference to iron metabolism. (1977) (7)
Polymyalgia rheumatica and giant cell arteritis--a difficult diagnosis. (1981) (6)
Rheumatoid factor and rheumatoid factor isotypes in loiasis with and without accompanying glomerulonephritis. (1992) (6)
Polymyalgia rheumatica/giant cell arteritis. (1983) (6)
96-well plate-based method for total collagen analysis of cell cultures. (2001) (6)
Routine quantitation of rheumatoid factors: ELISA or nephelometry? (1992) (5)
A longitudinal study of circulating immune complexes, dna antibodies and complement in patients with systemic lupus erythematosus: an analysis of their relationship to disease activity. (1979) (5)
Antibody-producing capacity in rheumatoid arthritis. (1973) (5)
Fast Facts: Soft Tissue Disorders (2006) (4)
Paired serum and synovial fluid values of alpha 2-macroglobulin and TIMP in rheumatoid arthritis. (1987) (4)
Heat Distribution over Joints:- The Normal and Abnormal Pattern (1984) (4)
Polymyalgia rheumatica and giant-cell arteritis [6] (2002) (4)
Diflunisal and aspirin: a comparative study in rheumatoid arthritis. (1980) (4)
Thermography of Tennis Elbow (1984) (4)
Clinical outcomes, quality of life and diagnostic uncertainty in the first year in polymyalgia rheumatica: A prospective cohort study (2006) (4)
In vitro lymphocyte cytotoxicity to cultured human arterial smooth muscle cells in patients with giant cell arteritis and polymyalgia rheumatica. (1981) (3)
Autoimmunity and the prolapsed intervertebral disc syndrome (2004) (3)
Acemetacin in the long-term therapy of rheumatoid arthritis. (1993) (3)
The treatment of persistent synovitis with nitrogen mustard. (1980) (3)
Managing the patient with polymyalgia. (2002) (2)
Thermography and Raynaud’s Syndrome (1984) (2)
Immunological and histological study of guinea-pigs injected with insoluble human elastin. (1987) (2)
Giant cell arteritis ofmyometrial andaxillary arteries andpolymyalgia rheumatica (1987) (2)
Effect of Short-Term Corticosteroid Administration on the Concentration of Serum Proteins (1995) (2)
Plasma levels and response to prednisolone therapy in rheumatoid arthritis (1983) (2)
Mortality rate is reduced in ra patients treated with TNF antagonists. Data from biobadaser (2006) (2)
Factors relating tocirculating immune complexes inrheumatoid arthritis (1976) (2)
The differential responses of human skin and synovial fibroblasts to stanozololin vitro: Production of prostaglandin E2 and matrix metalloproteinases (1992) (2)
Effects ofheparin, histamine, andsalmon calcitonin on mouse calvarial boneresorption (1986) (1)
Vasospastic disease, cold stress test, and prostaglandin E1 (1981) (1)
Giant-cell arteritis presenting to the dentist: a need for urgent diagnosis : J. Dent.11 (1983) 356–360 (1983) (1)
Microcomputer Standardization of the AGA 680M System (1984) (1)
Antibodies to intermediate filaments in polymyalgia rheumatica/giant cell arteritis: do they reflect the underlying disease activity rather than the acute phase response? (1994) (1)
High free and latent collagenase activity in psoriatic arthritis synovial fluid. (1995) (1)
Lymphocyte sensitivity to human skeletal muscle antigen in polymyositis. (1973) (1)
Pulsed intravenous methylprednisolone in the treatment of rheumatoid arthritis (1987) (1)
LYMPHOCYTE SUBPOPULATION ANALYSIS OF PERIPHERAL BLOOD IN POLYMYALGIA RHEUMATICA/GIANT CELL ARTERIES. AUTHOR'S REPLY (1994) (1)
Shoulder pain. (2002) (1)
Drug-induced syndromes and drug toxicity (1986) (1)
Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis (2004) (1)
Letters to the Editor (2001) (1)
Azathioprine: a controlled, double-blind trial in rheumatoid arthritis. (1969) (1)
Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis. (1994) (1)
Shoulder pain. (2002) (0)
Book Review: Seronegative Polyarthritis (1977) (0)
Rheumatoid arthritis : cellular pathology and pharmacology : proceedings of the Cambridge Rheumatism Research Group Symposium on Rheumatoid Arthritis-Cellular Pathology and Pharmacology, held in Cambridge, United Kingdom, 21-23 September 1976 (1977) (0)
A RANDOMISED PLACEBO-CONTROLLED TRIAL OF PHYSIOTHERAPY FOR ROTATOR CUFF TENDINOPATHIES (2008) (0)
Immunological studies in patients with rheumatoid arthritis receiving azathioprine and myocrisin in combination (1982) (0)
Clinical features at presentation in pulymyalgia rheumatica (PMR): Results from a multi-centre prospective cohort study (2004) (0)
arteritis . rheumatica and giant cell of patients with polymyalgia immune complexes from sera Isolation and analysis of (0)
Letters to the Editor (2001) (0)
Silicon nephropathy and myeloperoxidase antibodies (0)
A study of auto-antibodies to cyclic citrullinated peptide in a polymyalgia rheumatica inception cohort from the UKPMR outcomes study (2007) (0)
Successful treatment ofdissecting aortic aneurysm duetogiant cell arteritis (1981) (0)
Isolation andanalysis ofimmunecomplexes from seraofpatients withpolymyalgia rheumatica andgiantcellarteritis (1987) (0)
Shoulder pain. (2003) (0)
Polymyalgia rheumatica and giant-cell arteritis. (2002) (0)
Complex regional pain syndromes in the rheumatology clinic (2004) (0)
Authors' reply (1994) (0)
Sonographic assessment of shoulder complaints in rheumatic diseases. (1999) (0)
PAR9: THE IMPLICATIONS OF RHEUMATOID ARTHRITIS IN THE UK SECONDARY CARE HEALTH CARE SYSTEM (2003) (0)
Polymyalgia rheumatica and giant cell arteritis: Authors’ reply (1995) (0)
chapter 48 – Giant Cell Arteritis (2007) (0)
Circulating immune complexes inpolymyalgia rheumatica andgiant cell arteritis (1981) (0)
Inflammatory Joint Disease and Pain (2003) (0)
P40. Identification of tissue inhibitor of metalloproteinases-2 (TIMP-2)-progelatinase complex as the third metalloproteinase inhibitor peak in rheumatoid synovial fluid (1994) (0)
Quality of life, outcomes and diagnostic uncertainty in the first year in polymyalgia rheumatica (2006) (0)
Relationship oftheerythrocyte sedimentation rate to acutephase proteins inpolymyalgia rheumatica andgiantcell arteritis (1981) (0)
A suspected case of temporal arteritis. (2001) (0)
Recent Advances in Rheumatology (1976) (0)
Outcomes in the first year in polymyalgia rheumatica (PMR): Results from a multi-centre prospective cohort study (2005) (0)
The Shoulder Joint (1990) (0)
O14. The measurement of collagenase, tissue inhibitor of metalloproteinase (TIMF) and collagenase-TIMP complex in synovial fluids from osteo- and rheumatoid arthritis (1994) (0)
Survival of patients after lymphocytotoxic monoclonal antibody therapy for RA. (1998) (0)
Arthritis: a Quarter Century of Research (1978) (0)
Acute arthritis--2. (1977) (0)
Letters to the Editor (2001) (0)
Antibodies tointermediate filaments inpolymyalgia rheumatica andgiant cell arteritis: asequential study (1987) (0)
Anti-Inflammatory Drugs in vitro Inhibition of Tendon Cell Proliferation and Matrix Glycosaminoglycan Synthesis by Non-Steroidal (2001) (0)
Comprar The sclera and systemic disorders | P. Watson | 9781907816079 | Jaypee (2011) (0)
Shoulder pain. (2004) (0)
Safety and tolerability of rituximab in patients with moderate to severe rheumatoid arthritis: Results from the dose-ranging assessment international clinical evaluation of rituximab in rheumatoid arthritis (D A N C E R) study (2006) (0)
Authors' reply (1994) (0)
Polymyalgia rheumatica -- a clinical study with particular reference to arterial disease. (1974) (0)
Immunological and histological studies of temporal arteries 243 (0)
Drug treatment of connective tissue disease. (1974) (0)
Diseases of the bones and joints (2007) (0)
Authors' reply (1995) (0)
DIETARY MANIPULATION IN RHEUMATOID ARTHRITIS (1986) (0)
Causeofdeath inpatients withrheumatoid arthritis withparticular reference toazathioprine (1980) (0)
The shoulder joint. Foreword. (1989) (0)
chapter 41 – Polymyalgia Rheumatica (2007) (0)
matrix degeneration. tendon of calcium phosphate salt accumulation in Prevalence and possible pathological significance (2008) (0)
Complex regional pain syndromes: definitions and pathogenesis (2004) (0)
The effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism. (2001) (0)
Interaction ofInfluenza A Virus withHumanPeripheral Blood (1979) (0)
arteritis : a sequential study . rheumatica and giant cell filaments in polymyalgia Antibodies to intermediate (2004) (0)
Effects of single dose compared with three days' (0)

This paper list is powered by the following services:

Brian L. Hazleman's Academic­Influence.com Rankings

Why Is Brian L. Hazleman Influential?

Brian L. Hazleman's Published Works

Published Works

Brian L. Hazleman's AcademicInfluence.com Rankings